| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |